搜尋
Affimed NV
AFMD添加自選
0.181USD
0.0000.00%
收盤 06/30, 16:00（美東）報價延遲15分鐘
2.98M總市值
虧損本益比TTM
關於 Affimed NV 公司
Affimed NV 是一家臨牀階段的生物製藥公司，專注於發現和開發癌症免疫療法。該公司的候選產品是在免疫腫瘤學領域開發的，免疫腫瘤學代表了一種癌症研究方法，旨在利用人體自身的免疫系統對抗腫瘤細胞。其產品線包括 AFM13、AFM13 + 過繼性 NK 細胞、AFM13 + 抗 PD-1、AMF24、AMF26、AMF28 和 AMF32。該公司正在招募患者參加 AFM13 的註冊導向研究，用於治療 CD30 陽性復發/難治性外周 T 細胞淋巴瘤，以及 AFM24 的 1/2a 期劑量遞增/擴展研究，用於治療晚期 EGFR 表達實體瘤。其臨牀前候選產品包括用於治療多發性骨髓瘤的 AMF26，以及用於治療多種腫瘤靶點的 AMF28 和 AMF32。此外，該公司還與 Genentech 合作開發和商業化用於治療多種癌症的某些候選產品。
Affimed NV簡介
公司代碼AFMD
公司名稱Affimed NV
上市日期Sep 12, 2014
CEOMr. Shawn M. Leland
員工數量76
證券類型Ordinary Share
年結日Sep 12
公司地址Im Neuenheimer Feld 582
城市HEIDELBERG
上市交易所Berne Stock Exchange
國家Germany
郵編69120
電話49621560030
網址https://www.affimed.com/
公司代碼AFMD
上市日期Sep 12, 2014
CEOMr. Shawn M. Leland
Affimed NV公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. Wolfgang Fischer, Ph.D.
Dr. Wolfgang Fischer, Ph.D.
Chief Operating Officer, Member of the Management Board
Chief Operating Officer, Member of the Management Board
145.54K
+0.02%
Ms. Denise Mueller
Ms. Denise Mueller
Chief Business Officer and Co-President Affimed Inc, Member of the Management Board
Chief Business Officer and Co-President Affimed Inc, Member of the Management Board
89.88K
+0.07%
Dr. Andreas Harstrick, M.D.
Dr. Andreas Harstrick, M.D.
Chief Medical Officer, Member of the Management Board
Chief Medical Officer, Member of the Management Board
76.04K
+0.12%
Dr. Mathieu Simon
Dr. Mathieu Simon
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
15.00K
+0.24%
Mr. Harry Welten
Mr. Harry Welten
Consulting Chief Financial Officer, Member of the Management Board
Consulting Chief Financial Officer, Member of the Management Board
15.00K
+0.24%
Dr. Annalisa M. Jenkins
Dr. Annalisa M. Jenkins
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
14.00K
+0.12%
Ms. Uta Kemmerich-Keil
Ms. Uta Kemmerich-Keil
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
11.00K
+0.76%
Mr. Shawn M. Leland
Mr. Shawn M. Leland
Chief Executive Officer, Member of the Management Board
Chief Executive Officer, Member of the Management Board
--
--
Dr. Bernhard R. M. Ehmer
Dr. Bernhard R. M. Ehmer
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Dr. Thomas Hecht, M.D.
Dr. Thomas Hecht, M.D.
Independent Chairman of the Supervisory Board
Independent Chairman of the Supervisory Board
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Wolfgang Fischer, Ph.D.
Dr. Wolfgang Fischer, Ph.D.
Chief Operating Officer, Member of the Management Board
Chief Operating Officer, Member of the Management Board
145.54K
+0.02%
Ms. Denise Mueller
Ms. Denise Mueller
Chief Business Officer and Co-President Affimed Inc, Member of the Management Board
Chief Business Officer and Co-President Affimed Inc, Member of the Management Board
89.88K
+0.07%
Dr. Andreas Harstrick, M.D.
Dr. Andreas Harstrick, M.D.
Chief Medical Officer, Member of the Management Board
Chief Medical Officer, Member of the Management Board
76.04K
+0.12%
Dr. Mathieu Simon
Dr. Mathieu Simon
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
15.00K
+0.24%
Mr. Harry Welten
Mr. Harry Welten
Consulting Chief Financial Officer, Member of the Management Board
Consulting Chief Financial Officer, Member of the Management Board
15.00K
+0.24%
Dr. Annalisa M. Jenkins
Dr. Annalisa M. Jenkins
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
14.00K
+0.12%
常見問題
Affimed NV的前五大股東是誰？
Affimed NV的前五大股東如下：Dr. Wolfgang Fischer, Ph.D.
有多少機構持有Affimed NV(AFMD)的股份？
截至2026Q1，共有73家機構持有Affimed NV的股份，合計持有的股份價值約為1.13K，占公司總股份的0.01% 。與2025Q4相比，機構持股有所增加，增幅為-5189114.00。
